116 related articles for article (PubMed ID: 29621097)
61. Using ex vivo proton magnetic resonance spectroscopy to reveal associations between biochemical and biological features of meningiomas.
Pfisterer WK; Nieman RA; Scheck AC; Coons SW; Spetzler RF; Preul MC
Neurosurg Focus; 2010 Jan; 28(1):E12. PubMed ID: 20043716
[TBL] [Abstract][Full Text] [Related]
62. Anaplastic meningioma: progression from atypical and chordoid morphotype with morphologic spectral variation at recurrence.
Bollag RJ; Vender JR; Sharma S
Neuropathology; 2010 Jun; 30(3):279-87. PubMed ID: 19780983
[TBL] [Abstract][Full Text] [Related]
63. Integrative genomic analysis identifies CCNB1 and CDC2 as candidate genes associated with meningioma recurrence.
Bie L; Zhao G; Ju Y; Zhang B
Cancer Genet; 2011 Oct; 204(10):536-40. PubMed ID: 22137483
[TBL] [Abstract][Full Text] [Related]
64. Association between laminin γ1 expression and meningioma grade, recurrence, and progression-free survival.
Ke HL; Ke RH; Li B; Wang XH; Wang YN; Wang XQ
Acta Neurochir (Wien); 2013 Jan; 155(1):165-71. PubMed ID: 23053286
[TBL] [Abstract][Full Text] [Related]
65. Correlation between histological grade and MIB-1 and p53 immunoreactivity in meningiomas.
Ozen O; Demirhan B; Altinörs N
Clin Neuropathol; 2005; 24(5):219-24. PubMed ID: 16167545
[TBL] [Abstract][Full Text] [Related]
66. CD44 expression in human meningiomas: an immunohistochemical analysis.
Lewy-Trenda I; Omulecka A; Janczukowicz J; Papierz W
Pol J Pathol; 2004; 55(1):33-7. PubMed ID: 15195704
[TBL] [Abstract][Full Text] [Related]
67. The contribution of diffusion-weighted MR imaging to distinguishing typical from atypical meningiomas.
Hakyemez B; Yildirim N; Gokalp G; Erdogan C; Parlak M
Neuroradiology; 2006 Aug; 48(8):513-20. PubMed ID: 16786348
[TBL] [Abstract][Full Text] [Related]
68. Long-term survival analysis of atypical meningiomas: survival rates, prognostic factors, operative and radiotherapy treatment.
Hammouche S; Clark S; Wong AH; Eldridge P; Farah JO
Acta Neurochir (Wien); 2014 Aug; 156(8):1475-81. PubMed ID: 24965072
[TBL] [Abstract][Full Text] [Related]
69. Recurrent meningiomas--the immunohistochemical analysis of angiogenesis and cellular proliferation. Preliminary study.
Izycka-Swieszewska E; Rzepko R; Borowska-Lehman J; Baranowska E; Warzocha D
Folia Neuropathol; 1999; 37(3):179-84. PubMed ID: 10581855
[TBL] [Abstract][Full Text] [Related]
70. Correlation of histopathologic classification with proliferative activity and DNA ploidy in 120 intracranial meningiomas, with special reference to atypical meningioma.
Myong NH; Chi JG
J Korean Med Sci; 1997 Jun; 12(3):221-7. PubMed ID: 9250918
[TBL] [Abstract][Full Text] [Related]
71. Recurrence of meningiomas.
Yamasaki F; Yoshioka H; Hama S; Sugiyama K; Arita K; Kurisu K
Cancer; 2000 Sep; 89(5):1102-10. PubMed ID: 10964341
[TBL] [Abstract][Full Text] [Related]
72. High p-mTOR expression is associated with recurrence and shorter disease-free survival in atypical meningiomas.
Barresi V; Lionti S; La Rocca L; Caliri S; Caffo M
Neuropathology; 2019 Feb; 39(1):22-29. PubMed ID: 30511495
[TBL] [Abstract][Full Text] [Related]
73. Osteopontin expressions correlate with WHO grades and predict recurrence in meningiomas.
Arikök AT; Onder E; Seçkin H; Kaçar A; Fesli R; Oğuz AS; Alper M
Brain Tumor Pathol; 2014 Apr; 31(2):94-100. PubMed ID: 23793814
[TBL] [Abstract][Full Text] [Related]
74. Telomerase activity and expression of the telomerase catalytic subunit, hTERT, in meningioma progression.
Simon M; Park TW; Leuenroth S; Hans VH; Löning T; Schramm J
J Neurosurg; 2000 May; 92(5):832-40. PubMed ID: 10794298
[TBL] [Abstract][Full Text] [Related]
75. [Molecular biology, diagnosis, and therapy of meningiomas].
Mawrin C
Pathologe; 2019 Sep; 40(5):514-518. PubMed ID: 31435780
[TBL] [Abstract][Full Text] [Related]
76. [Revised WHO classification and new developments in diagnosis of central nervous system tumors].
Wiestler OD; Wolf HK
Pathologe; 1995 Jul; 16(4):245-55. PubMed ID: 7667206
[TBL] [Abstract][Full Text] [Related]
77. DDX3X: structure, physiologic functions and cancer.
Mo J; Liang H; Su C; Li P; Chen J; Zhang B
Mol Cancer; 2021 Feb; 20(1):38. PubMed ID: 33627125
[TBL] [Abstract][Full Text] [Related]
78. DDX3X Multifunctionally Modulates Tumor Progression and Serves as a Prognostic Indicator to Predict Cancer Outcomes.
Lin TC
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31906196
[TBL] [Abstract][Full Text] [Related]
79. Comparison of fresh/frozen isolation method in DNA preparation of meningiomas for flow cytometry.
Tai SH; Lin YW; Chen TY; Huang YH; Hung YC; Lee EJ
Int J Clin Exp Pathol; 2017; 10(11):11057-11062. PubMed ID: 31966452
[TBL] [Abstract][Full Text] [Related]
80. [Electro-clinical elements in the diagnosis of recurrence of meningiomas].
Supino-Viterbo V; Gaches J
Rev Electroencephalogr Neurophysiol Clin; 1976; 6(3):431-5. PubMed ID: 1013496
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
